NGO · Germany · EU Transparency Register 429157047185-81
4
positions filed
in the 665 files tracked
4
legislative files
of 665 tracked
2
with a full position paper
attached to a submission
Counts here are a floor, never a total: they cover the 665 consultation files tracked so far (57,774 submissions, mostly 2021–26), so an organization's real filing history is larger, not smaller.
Who they are
Among the 1106 non-governmental organisations on this site, they rank #346 by legislative files engaged, a count of participation, not a measure of influence.
0.1
declared lobbying FTE
self-declared
–
declared costs / yr (floor)
0
EP accreditations
as declared to the register
2022
in the register since
Declares membership of
VBIO/German Life Sciences Association is the umbrella organisation of a number of learned societes
See https://www.vbio.de/fachgesellschaften (german only)
Our cooperation with other (mostly scientific) institutions is based on certain issues, not structures.
See https://www.vbio.de/kooperationen
Self-declared to the EU Transparency Register (snapshot 14 Oct 2026).
Register category
Non-governmental organisations
Registered as
Verband Biologie, Biowissenschaften und Biomedizin in Deutschland (VBIO e. V.) - German Life Sciences Association (VBIO)
Head office
München, Germany
EU office
Berlin
Self-declared to the EU Transparency Register (snapshot 14 Oct 2026); cost bands are floors, not audited totals. Reused under Commission Decision 2011/833/EU.
Work at German Life Sciences Association (VBIO e. V.)? so we know who speaks for it.
Their record over time
German Life Sciences Association (VBIO e. V.) filed 4 positions between 11 Feb 2026 and 28 Sept 2026, across 4 of the 665 legislative files tracked here, attaching a full position paper 2 times.
I. Ground conflict: There is a need to protect scientific freedom and strategic protection of knowledge biotechnological knowledge as strategic knowledge. However, strategic governance, security interests and economic exploitation constraints interfere with the day-to-day life of research and can create contradictions with regard to the freedom of research and teaching. ‘II.
Filed in German · English published by the European Commission
The Biotech Act II is intended as an extension of the Biotech Act I to the field of application of industrial biotechnology and production. Both Acts focus on increasing the EU’s industrial competitiveness in biotechnology and biomanufacturing. This focus on late stages of the innovation chain is legitimate, but in the view of the German Life Sciences Association (VBIO) is not sufficient.
Filed in German · English published by the European Commission
The VBIO has been advocating for a differentiated view of genome-edited plants since 2016 and welcomes the distinction of genomed plants into the NGT-1 and NGT-2 categories provided for in Regulation (EU) 2026/1388. We expect the EU Regulation to facilitate the translation of research results into practice.
Filed in German · English published by the European Commission
Submission on behalf of the Alliance of University and Non-University Biodiversity Research in Germany and the Consortium of European Taxonomic Facilities (CETAF). >>> Please find additional remarks and recommendations attached (pdf). EFFECTIVENESS Q1 The ABS Reg has supported compliance with the Nagoya Protocol (NP) and to clarify individual and institutional responsibilities.
Looking for an argument rather than an organization? Search every submission for a phrase and see everyone who used it.
Put German Life Sciences Association (VBIO e. V.) next to another organization. Same files, same register facts, side by side. Compare →
Turns up on the same files
Organizations that also filed on at least two of the same consultations. A shared interest in the same dossiers, not evidence of coordination, and we do not suggest any.
Everything on this page comes from German Life Sciences Association (VBIO e. V.)’s own submissions to the European Commission. We have added nothing and interpreted nothing. If something is wrong or out of date, email info@policyspeak.com and we will correct it. If you are an individual named in a record, our privacy policy sets out your rights to correction, objection and removal.
Quotes are verbatim from submissions published by the European Commission, trimmed to their opening passage and never summarized by a model. Organizations only, never individuals. Reused under Commission Decision 2011/833/EU; the European Commission is not liable for this reuse.